NCT00385931View on ClinicalTrials.gov

Efficacy and Safety of Valsartan and the Combination of Valsartan and Simvastatin

PHASE3CompletedINTERVENTIONAL
Enrollment

412

Participants

Timeline

Start Date

January 31, 2002

Primary Completion Date

April 30, 2003

Study Completion Date

April 30, 2003

Conditions
HypertensionHypercholesterolemiaDyslipidemia
Interventions
DRUG

Valsartan and simvastatin

Trial Locations (1)

07936

Novartis Pharmaceuticals, East Hanover

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY